106 related articles for article (PubMed ID: 29898077)
1. Circulating levels of neurotrophic factors are unchanged in patients with Parkinson's disease.
Rocha NP; Ferreira JPS; Scalzo PL; Barbosa IG; Souza MS; Christo PP; Reis HJ; Teixeira AL
Arq Neuropsiquiatr; 2018 May; 76(5):310-315. PubMed ID: 29898077
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophic factors in Parkinson's disease are regulated by exercise: Evidence-based practice.
da Silva PG; Domingues DD; de Carvalho LA; Allodi S; Correa CL
J Neurol Sci; 2016 Apr; 363():5-15. PubMed ID: 27000212
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
Salehi Z; Mashayekhi F
J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558
[TBL] [Abstract][Full Text] [Related]
4. [Associations of serum neuromarkers with clinical features of Parkinson's disease].
Nikitina MA; Koroleva ES; Brazovskaya NG; Boyko AS; Levchuk LA; Ivanova SA; Alifirova VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):145-152. PubMed ID: 38676689
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor.
Huang Y; Yun W; Zhang M; Luo W; Zhou X
J Int Med Res; 2018 Apr; 46(4):1477-1485. PubMed ID: 29350074
[TBL] [Abstract][Full Text] [Related]
6. Plasma Exosomal Brain-Derived Neurotrophic Factor Correlated with the Postural Instability and Gait Disturbance-Related Motor Symptoms in Patients with Parkinson's Disease.
Chung CC; Huang PH; Chan L; Chen JH; Chien LN; Hong CT
Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32932791
[TBL] [Abstract][Full Text] [Related]
7. Levels of cortisol and neurotrophic factor brain-derived in Parkinson's disease.
Costa CM; Oliveira GL; Fonseca ACS; Lana RC; Polese JC; Pernambuco AP
Neurosci Lett; 2019 Aug; 708():134359. PubMed ID: 31265872
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis.
Rahmani F; Saghazadeh A; Rahmani M; Teixeira AL; Rezaei N; Aghamollaii V; Ardebili HE
Brain Res; 2019 Feb; 1704():127-136. PubMed ID: 30296429
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of neurotrophic factors in autism spectrum disorders.
Rodrigues DH; Rocha NP; Sousa LF; Barbosa IG; Kummer A; Teixeira AL
Neuro Endocrinol Lett; 2014; 35(5):380-4. PubMed ID: 25275256
[TBL] [Abstract][Full Text] [Related]
10. Levels of IL-8 and TNF-α decrease in Parkinson's disease.
Gupta V; Garg RK; Khattri S
Neurol Res; 2016 Feb; 38(2):98-102. PubMed ID: 27078697
[TBL] [Abstract][Full Text] [Related]
11. Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis.
Jiang L; Zhang H; Wang C; Ming F; Shi X; Yang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():168-174. PubMed ID: 30017781
[TBL] [Abstract][Full Text] [Related]
12. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
Dursun E; Gezen-Ak D; Hanağası H; Bilgiç B; Lohmann E; Ertan S; Atasoy İL; Alaylıoğlu M; Araz ÖS; Önal B; Gündüz A; Apaydın H; Kızıltan G; Ulutin T; Gürvit H; Yılmazer S
J Neuroimmunol; 2015 Jun; 283():50-7. PubMed ID: 26004156
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
Rocha NP; Teixeira AL; Scalzo PL; Barbosa IG; de Sousa MS; Morato IB; Vieira EL; Christo PP; Palotás A; Reis HJ
Mov Disord; 2014 Apr; 29(4):527-31. PubMed ID: 24301904
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients.
Munkholm K; Pedersen BK; Kessing LV; Vinberg M
Psychoneuroendocrinology; 2014 Sep; 47():199-211. PubMed ID: 25001969
[TBL] [Abstract][Full Text] [Related]
16. Association of low serum BDNF with depression in patients with Parkinson's disease.
Wang Y; Liu H; Du XD; Zhang Y; Yin G; Zhang BS; Soares JC; Zhang XY
Parkinsonism Relat Disord; 2017 Aug; 41():73-78. PubMed ID: 28576603
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of adipokines in Parkinson's disease.
Rocha NP; Scalzo PL; Barbosa IG; de Sousa MS; Morato IB; Vieira EL; Christo PP; Reis HJ; Teixeira AL
J Neurol Sci; 2014 Apr; 339(1-2):64-8. PubMed ID: 24495872
[TBL] [Abstract][Full Text] [Related]
18. Correlational study of the serum levels of the glial fibrillary acidic protein and neurofilament proteins in Parkinson's disease patients.
Su W; Chen HB; Li SH; Wu DY
Clin Neurol Neurosurg; 2012 May; 114(4):372-5. PubMed ID: 22206859
[TBL] [Abstract][Full Text] [Related]
19. Migraine is associated with altered levels of neurotrophins.
Martins LB; Duarte H; Ferreira AV; Rocha NP; Teixeira AL; Domingues RB
Neurosci Lett; 2015 Feb; 587():6-10. PubMed ID: 25524411
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic Factors in Parkinson's Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
Ferreira RN; de Miranda AS; Rocha NP; Simoes E Silva AC; Teixeira AL; da Silva Camargos ER
Curr Med Chem; 2018; 25(31):3682-3702. PubMed ID: 29532753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
